Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2010

Consumers’ use of web-based information and their decisions
about multiplex genetic susceptibility testing
Kimberly A. Kaphingst
Washington University School of Medicine in St. Louis

Colleen M. McBride
National Institutes of Health

Christopher Wade
National Institutes of Health

Sharon H. Alford
Henry Ford Hospital

Lawrence C. Brody
National Institutes of Health

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Kaphingst, Kimberly A.; McBride, Colleen M.; Wade, Christopher; Alford, Sharon H.; Brody, Lawrence C.;
and Baxevanis, Andreas D., ,"Consumers’ use of web-based information and their decisions about
multiplex genetic susceptibility testing." Journal of Medical Internet Research. 12,3. e41. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/4065

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Kimberly A. Kaphingst, Colleen M. McBride, Christopher Wade, Sharon H. Alford, Lawrence C. Brody, and
Andreas D. Baxevanis

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/4065

8/11/2015

Consumers’ Use of WebBased Information and Their Decisions About Multiplex Genetic Susceptibility Testing

J Med Internet Res. 2010 JulSep; 12(3): e41.

PMCID: PMC2956320

Published online 2010 Sep 29. doi: 10.2196/jmir.1587

Consumers’ Use of WebBased Information and Their Decisions About
Multiplex Genetic Susceptibility Testing
Monitoring Editor: Gunther Eysenbach
Reviewed by Celeste Condit, CheMing Yang Yang, and Jogenananda Pramanik
Kimberly A Kaphingst, ScD, 1 Colleen M McBride, PhD, 1 Christopher Wade, PhD MPH, 1 Sharon Hensley Alford, PhD, 3
Lawrence C Brody, PhD, 2 and Andreas D Baxevanis, PhD2
3
Department of Biostatistics and Research Epidemiology, Henry Ford Hospital, Detroit, MI, USA
2
Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
1
Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda MD, USA
Kimberly A Kaphingst, Health Communication Research Laboratory, Washington University in St Louis, 700 Rosedale Avenue, Campus Box
1009, St Louis, MO 63112, United States, Phone: 1 314 935 3726, Fax: 1 314 935 3757, Email: kkaphingst@gwbmail.wustl.edu.
Corresponding author.
Received 2010 Jun 16; Revisions requested 2010 Jul 6; Revised 2010 Jul 17; Accepted 2010 Aug 4.
Copyright The substantive content of this work is a U.S. Government work product and not subject to copyright.
This is an openaccess article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original
work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original
publication on http://www.jmir.org/, as well as this copyright and license information must be included.

Abstract
Background

Few data exist to inform concerns raised by online directtoconsumer marketing of genetic susceptibility
tests, such as those offered by commercial entities like 23andme, Navigenics, and DNA Direct. The
Multiplex Initiative, a populationbased study of healthy adults, provides the first opportunity to evaluate
how use of a Webbased decision tool that conveyed information about a genetic susceptibility test
influenced individuals’ test decisions.
Objective

To inform the ongoing debate over whether individuals offered genetic susceptibility testing without the
involvement of a health care provider (eg, through directtoconsumer testing) can make informed decisions
about testing when guided by online decision aids.
Methods

Participants were 526 members of a large health maintenance organization aged 25 to 40 years old who
visited a study website. Multivariate logistic regression models were tested to examine the association of
website usage with downstream test decisions.
Results

Participants viewed an average of 2.9 of the 4 pages introducing the multiplex test, 2.2 of the 8 pages
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956320/?report=printable
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describing the health conditions, and 3.2 of the 15 pages describing the genes. For each page viewed,
participants were more likely to describe their decisionmaking as easy (odds ratio [OR] 1.04, 95%
confidence interval [CI] 1.011.07) and to decide to be tested (OR 1.08, 95% CI 1.051.11).
Conclusions

Healthy adults in this study perceived Webbased genomic information presented using evidencebased
communications approaches to be helpful in supporting both decisions to test and not to test. Continued
research is needed to ensure that these results generalize to target groups with lower literacy and less Internet
savvy.
Keywords: Genetic testing/methods, genetic testing/psychology, genetic predisposition to
disease/psychology, health knowledge, attitudes, practice, health surveys, internet/utilization, polymorphism,
single nucleotide, public health/methods, risk assessment/methods
Introduction
Several new genetic tests provide individuals with information about their susceptibilities to a wide array of
common health conditions. The availability of these tests is expected to increase greatly over the next decade
as more genedisease associations are identified [1]. Despite the lack of data on clinical effectiveness,
commercial entities are even now marketing such tests online directly to consumers (eg, 23andme,
Navigenics, and DNA Direct), a practice growing in prominence in the United States [14]. This report
presents data from the Multiplex Initiative [5,6] to inform the ongoing debate over whether individuals
offered genetic susceptibility testing without the involvement of a health care provider—that is, directto
consumer (DTC)—can make informed decisions about testing when guided by online decision aids.
One of the most hotly contested issues has been focused on the challenges of communicating complex
information about genetic risk for common, chronic diseases [7,8]. Given the complex etiology of common
diseases, critics have expressed concern that the public will not understand genomic information without the
assistance of a health care provider and will be unable to make informed decisions about taking genetic
susceptibility tests [7,9,10]. Of particular concern is whether individuals can understand the limitations of the
information generated by these tests and appreciate what cannot be learned from such tests [7].
Directtoconsumer companies’ reliance on interactive Webbased approaches adds complexity to these
communication issues [11,12]. The Internet increases dissemination potential, thereby enabling reach to ever
increasing proportions of the population with health information and genetic testing [5,13,14]. However,
Webbased approaches also may be inadequate for communicating complex genetic susceptibility
information, particularly for individuals with limited computer or health literacy skills, when compared with
interpersonal approaches [15,16,17]. Indeed, existing DTC marketing websites have been shown to use
language that is too difficult for most of the US public to comprehend and to have limited content in areas
that may be critical for decisionmaking [18].
Most prior research regarding comprehension and uptake of genetic testing has occurred in the context of
highrisk familial cancer syndromes. The majority of those who present for such testing have already decided
to be tested [19,20]. These studies, therefore, have provided little insight into differences among those who
decide to be tested and those who considered testing but decided not to test or into whether online
information can support such decisionmaking. To date, there have been no populationbased studies
evaluating whether or not individuals can use information made available online to make an informed
decision about testing. These questions can be examined using data generated by the Multiplex Initiative [1].
The Multiplex Initiative was designed to develop the infrastructure needed to evaluate a multiplex test (ie, a
test that includes multiple genetic variants for multiple health conditions) taken by healthy adults insured
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956320/?report=printable
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through a large managed care organization. The study provided the first opportunity to systematically present
genetic susceptibility information based upon best communication practices and then to examine individuals’
responses to the information. Despite the fact that testing was offered at no cost and the target population was
insured, we reported previously that those who logged on to a study website to consider testing and
subsequently elected to be tested were significantly more likely to be college educated and white than those
who did not log on or were not interested in testing [6].
In this report, we pose three specific research questions: (1) How do participants in the Multiplex Initiative
engage with different content areas of information provided on the website? (2) How do participants rate the
quality and usefulness of the website information? (3) Is website use associated with decisions about genetic
testing?
Methods
Study Design and Participants

The Multiplex Initiative has previously been described in detail [6]. In brief, study participants were selected
from a pool of 350,000 members of a large Midwestern health maintenance organization. Selection criteria
included being between the ages of 25 and 40 years, having been enrolled in the plan for at least two years,
and not having any of the health conditions included on the Multiplex test. Groups traditionally
underrepresented in genetics research (ie, men, blacks, and those with lower education) were oversampled as
described in detail elsewhere [6]. All procedures were approved by the institutional review boards of the
National Human Genome Research Institute and the Henry Ford Health System.
A baseline telephone assessment was attempted with 6348 sampled individuals. Of these, 1930 completed
the assessment and were invited to visit the study website. Individuals completed a consent process as part of
the initial Web module. Participants were told that they would be asked to complete brief questionnaires and
to review Web content. A total of 612 individuals visited the website, and 527 completed all four website
based assessments. Although website visitors who did not complete all four assessments were similar to
those who completed all assessments based on age, gender, educational attainment, and marital status, white
participants were more likely to complete all assessments than black participants (P = .002). Following
completion of the website portion of the study, interested individuals completed an in person clinic visit, and
then a blood draw was performed on those individuals who decided to undergo testing. The analyses
presented here are based on 526 individuals who visited the website, completed all four website assessments,
and for whom data regarding the testing decision were available. These 526 individuals had a mean age of
34.6 years. Half (263/526) were white. A majority were female (297/526 or 56.5%), and most were married
or in a partnered relationship (336/526 or 63.9%).
Website Content

The content of the Multiplex Initiative study website was developed by an interdisciplinary team of
researchers, drawing on prior research and best practices in health literacy and risk communication. Health
literacy principles were used to develop the information content of the website. For example, the scope of the
content was limited to what the team considered the most essential information needed to support participant
decisionmaking [21]. In addition, the information was organized using a layered approach [21,22].
Participants were offered a menu of content topics and could then choose the order and amount of content
reviewed, allowing those participants who wanted more detailed content to find that information. We
avoided using technical jargon where possible (eg, using “risk version” instead of “riskincreasing gene
variant”) and defined jargon where it was used (eg, “a risk factor is anything that increases your chance of
getting a health condition”). We drew upon prior risk communication research to convey risk information on
the website. For example, risk estimates were given using an “n in 100” format, which prior research has
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956320/?report=printable
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shown to convey risk information best to lay individuals [23,24]. In addition, we selected pictograph
graphics to visually convey the risk information, a type of graphic that has been shown to convey this
information to lay audiences more effectively than alternative graphic formats [24].
The website content was organized into four modules: (1) Multiplex Genetic Testing: What it Can and
Cannot Tell You; (2) Diseases and Genes on the Multiplex Genetic Test; (3) Your Rights if You Take Part
in Multiplex Genetic Research; and (4) Your Decision to be Tested or Not (see Textbox 1). Two examples
of website pages are shown in Figures 1 and 2. The participants received small incentives (gift cards up to
US $50 from a national retail chain) for completing the website assessments.
Study website content and assessment points

Module 1: Multiplex Genetic Testing: What it Can and Cannot Tell You (4 pages)

Content topics

Definition of multiplex genetic testing
Testing procedures
Overview of health conditions and genes
Meaning of “genetic risk”
Importance of health habits and other factors in disease risk
Module 2: Diseases and Genes on the Multiplex Genetic Test (23 pages)

Content topics

For the eight health conditions:
Description of condition
Known risk factors for condition
Genes that affect risk of condition
For the 15 genes:
Brief description of gene action
Increased risk associated with gene variant
Prevalence of riskincreasing gene variant in population
Limitations of what is known about genedisease association
Scientific references
Assessment used in analysis

· Perceptions of website information in Module 2
Module 3: Your Rights if You Take Part in Multiplex Genetic Research (4 pages)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956320/?report=printable
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Content topics

Researcher responsibilities
Rights of research participants
Test procedures
Module 4: Your Decision to be Tested or Not (1 page)

Assessments used in analysis

Ease or difficulty of decision making
Interest in making clinic appointment

Website Tracking

Each study participant was given a unique login ID/password pair that enabled their visit to the Multiplex
website to be tracked. Each time a page on the website was accessed, a tracking database stored the
participant’s unique login ID, the session number for that user (ie, whether this was their first, second, or
subsequent visit to the Multiplex website), and the date and time that the page was requested. Login IDs
were randomly generated and created so that the responses of a particular individual could not be identified.
Measures

The measures included in the report were collected at three time points: baseline telephone assessment,
website assessments (about 1 to 2 weeks after baseline), and whether individuals attended the clinic visit for
a blood draw (up to 60 days after baseline).
Outcome Variables The

primary outcome variable, ease of decision making, was assessed in the fourth
website module (see Textbox 1). Participants were asked on a 7point Likert scale to “tell us how easy or
hard it is for you to decide whether or not to get multiplex genetic testing.” Due to the skewed distribution,
responses were dichotomized at the midpoint. The second outcome was whether participants had blood
drawn for testing.
Predictor Variable The

primary predictor variable was the number of website pages viewed for each module.
Each page was assigned a value of 0 or 1 depending on whether or not participants viewed that page. The
number of pages viewed was then summed overall and within content areas.
Mediating Variable Individuals’ perceptions of the

content of the second module (see Textbox 1), which
described the health conditions and genes on the test, were rated with respect to trustworthiness,
satisfactoriness, helpfulness, and clarity of the information (eg, “I trusted that the information presented was
true”). Participants indicated strength of agreement with each item on 7point Likert scales ranging from
“strongly disagree” to “strongly agree.” Four items were reverse coded so that “strongly agree” reflected
more positive perceptions for all items. The standardized Cronbach alpha was .76.
Covariates Covariates assessed

were based on the Risk Information Seeking and Processing Model [25].
Sociodemographic covariates included gender, age, educational attainment, race, and marital status.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956320/?report=printable
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Participants also identified which multiplex health conditions ran in their family. A 6item measure of genetic
selfefficacy was adapted from Parrott et al [26]. The items (eg, “You would be able to explain to others how
genes affect health”) were answered on 7point Likert scales ranging from “strongly disagree” to “strongly
agree.” Health information seeking was assessed using the item, “In the past 30 days, how often would you
say you have looked for information about ways to stay healthy or to feel better?” Responses were
dichotomized as daily or weekly versus less than weekly or never. Importance of genetic information was
assessed with the item, “How important is it to you to learn more about how your genes affect your chance
of getting certain health conditions?” Response choices ranged from 1, not at all important to 7, very
important.
Analysis

Data were analyzed using SAS Version 9.2 for Windows (SAS Institute Inc, Cary, NC, USA). Descriptive
statistics were first examined for all variables. Differences by the predictor variable, possible mediating
variable, and covariates in the two outcome variables were assessed using chisquare tests. We then tested
multivariate logistic regression models to evaluate the association of number of pages viewed with the two
outcome variables, employing forward checking and backward elimination methods to determine which
covariates to include in the final models [27]. We used a P < .20 criterion for inclusion of covariates [28,29].
The potential mediator was tested using the approach of Baron and Kenny [30]. Statistical significance was
assessed as P < .05.
Results
Participant Engagement With Website

Of the 27 possible pages in modules 1 and 2 (Textbox 1), participants viewed, on average, about 8 pages
(mean 8.2, standard deviation [SD] 7.2), although the number of pages viewed ranged from 1 to 27. On
average, participants viewed about 2.9 of the 4 pages introducing the multiplex test, 2.2 of the 8 pages
describing the health conditions on the test, and 3.2 of the 15 pages describing the genes. Over 60%
(326/526) of participants viewed the Web page for diabetes, which was the first health condition listed on the
website menu. However, less than 25% of participants viewed any of the other health condition pages.
Similarly, between 40% and 50% viewed the first gene pages listed on the website menu (for KCNJ11,
CAPN10, PPARG, and TCN7L2), but less than 20% viewed any of the other genes pages. Education was
the only significant sociodemographic predictor of the number of Web pages viewed in the multivariate
model. Participants with a high school degree or less viewed about 3 1/2 pages fewer, on average, than
participants with a college degree or higher (beta = 3.52, P < .001), while participants with some college
viewed about 2 pages fewer than those with a college degree or higher (beta = 2.10, P = .002).
In bivariate analyses, the number of pages viewed was associated with each of the two outcomes (see
Table 1). The group of participants who rated their decision to test as easy had looked at more pages within
each content area than those who rated the decision as difficult. This difference was about a half page for
general test information (P = .001) and health condition information (P = .02) and about a page for gene
information (P = .003). Similarly, participants who had blood drawn for the test had viewed more website
content than those who declined testing, with differences of about 1 page for information about the test and
the health conditions and about 2 pages for information about the genes (P < .001).
Participant Ratings of Quality and Usefulness of Information About Health Conditions and Genes

Participants rated the quality and usefulness of the information about the health conditions and genes
positively. These ratings were significantly associated with each of the two outcomes (see Table 1).
Participants who rated their decision as easy perceived the website information more positively overall than
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956320/?report=printable
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those who rated their decision as difficult (P < .001). This general pattern was also true for individual ratings
of trustworthiness of the information (P < .001), satisfaction (P < .001), ease of understanding (P < .001),
feeling able to understand the information (P < .001), helpfulness of the information (P < .001), needing
minimal effort to understand the information (P < .001), and sufficiency of the information (P = .033).
Individuals who decided to test rated the website information more positively than those who declined testing
(P < .001). In the individual ratings, participants who decided to test rated the trustworthiness (P = .038),
satisfactoriness (P < .001), ease of understanding (P = .010), and helpfulness of the information (P = .001)
more positively than those who declined the test.
Association of Website Usage With DecisionMaking

As shown in Table 2, the number of pages viewed was significantly associated with ease of decisionmaking
in multivariate analyses (odds ratio [OR] 1.04, 95% confidence interval [CI] 1.011.07). The results of this
model showed that for every page viewed, participants were about 4% more likely to describe their decision
as easy, on average, controlling for the sociodemographic and psychological covariates. In this model,
genetic selfefficacy and involvement with genetic information were significant covariates. Participants with
higher genetic selfefficacy (OR 1.27, 95% CI 1.051.52) and who placed greater importance on genetic
information (OR 1.18, 95% CI 1.031.36) were more likely to describe their decision to test or not as easy.
As shown in Table 3, the number of pages viewed also was significantly associated with deciding to test
(OR 1.08, 95% CI 1.051.11). For every page viewed, participants were about 8% more likely to decide to
test, controlling for the sociodemographic and psychological covariates. In this model, education, genetic
selfefficacy, and involvement with genetic information were also significant covariates. Individuals with a
high school degree or less were about half as likely to be tested compared with those with a college degree or
higher (OR 0.51, 95% CI 0.290.88). Participants with higher genetic selfefficacy (OR 1.24, 95% CI 1.03
1.50) and those who placed greater importance on genetic information (OR 1.24, 95% CI 1.071.44) were
more likely to test.
We tested whether perceptions of the quality and usefulness of the information about the health conditions
and genes mediated the significant associations of number of pages viewed with decision outcomes. In the
first step, we found a low correlation between the number of Web pages viewed and perceptions of the
information (r = .097). Therefore, we did not proceed to additional steps to test mediation and concluded that
perceptions of the website information did not mediate the associations.
Discussion
This report describes unique data suggesting how individuals respond to Webbased offers of genetic
susceptibility tests. This is especially notable because multiplex genetic susceptibility tests currently being
offered by many DTC companies have unknown clinical utility. We examined test decisions in a population
based sample where nearly half of participants who visited the website to consider testing ultimately decided
not to be tested. This is in contrast to most of the prior genetic testing literature, in which the majority of
study participants already had decided to obtain a genetic test [19,20].
Individuals generally had positive perceptions of the quality and usefulness of the website information.
Viewing more of the information was associated with finding it easier to decide about testing regardless of
whether the individual decided to test or not. Thus, patients found the website helpful in supporting their
decisionmaking—both the decision to test and the decision not to test.
In addition, the results presented here shed light on aspects of the online information that might be most
useful in supporting individuals’ decisionmaking. Participants engaged most with the introductory section
that described the test, testing procedures, and what could and could not be learned from the results. This
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956320/?report=printable
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suggests that this information may have been most relevant for their test decisions. In contrast, individuals
generally did not delve very deeply into content related to health conditions and gene pages. However, it is
noteworthy that participants who described their decision to test as easiest had viewed more of the pages
describing the health conditions and genes than those who found it harder to decide. This suggests that more
extensive processing about the specifics of the genetic test might have made it easier to decide about testing.
The findings observed here underscore the importance of attending to best communication practices such as
layering information in website development. For example, we placed the most important information about
the test in the introductory module and then supplemented that with detailed information about each health
condition and gene on separate pages. We believe that our observation that participants generally viewed
little of the detailed information supports using health literacy best practices. Specifically, the results suggest
that information thought to be most essential to individual decisionmaking be presented first [21,22]. By
contrast, a recent analysis of websites offering genetic tests directly to consumers showed that there is wide
variability in the content, language, and organizational structure of these sites [18], differences likely to
greatly influence their usefulness to consumers.
Despite our attention to health literacy issues (such as reducing technical jargon) in the design of this website,
the results showed that educational attainment was the primary predictor of how much information
participants viewed. Prior Multiplex Initiative analyses also have shown that educational attainment was
associated with whether participants logged onto the website [6]. Supplemental or alternative approaches
may be needed to facilitate decisionmaking among participants with more limited educational attainment or
health literacy skills. Individuals with limited health literacy may face substantial challenges in using Web
based information about genomics [16,17], and such consumers might face particular difficulties in making
decisions about DTC genetic susceptibility testing [18]. Other factors may also influence the effectiveness of
this type of Webbased educational approach, including computer literacy, genetic literacy, and decision
making preferences, all of which are important areas for future research.
Although this populationbased study had many strengths, the limitations should also be considered. The
observational design did not allow us to examine the effects of individual Web design features or to
investigate the effects of the educational material separately from the cognitive characteristics of the
participants. For example, some of the observed results may be affected by educational differences in
preferences for (or competencies in) reading lengthier text. These are important issues that could be
considered in experimental labbased studies, perhaps with analyses stratified by educational attainment or
cognitive characteristics such as information seeking preferences. Similarly, we were not able to drill down
to specific information content and decisions about testing. In addition, although we initially drew a
populationbased sample, participants who logged on to consider genetic testing were more educated and
savvier Internet users. Thus, these results may not generalize beyond these early adopters.
The results of this analysis show that consumers perceived a carefully designed website consistent with best
practices in communication to be helpful in deciding about genetic susceptibility testing. Critical next steps in
this area will be to examine individuals’ understanding and interpretation of such website information and
how it affects responses to test feedback. For example, is better understanding of the limitations of genetic
susceptibility testing associated with more accurate interpretations of test feedback?
As genomic discovery advances, Webbased delivery likely will continue and expand as an avenue for
education and decision support regarding genetic testing. These results suggest that individuals perceive
Webbased tools designed based on evidencebased communication approaches as supporting decision
making about genetic testing in some target groups. However, continued research is needed to ensure that
these tools or other appropriate decision support approaches are available to all groups including those
having lower literacy.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956320/?report=printable
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Example website page providing information about Multiplex Genetic Testing
Figure 2
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Example website page providing information about a gene on the test
Table 1

Association of website content viewed and ratings of content with decision outcomes (n = 526)
Ease of Decision

Test Decision

Easy Decision

Difficult Decision

Received Test

(n = 337)

(n = 186)

(n = 266)

Mean (SD)

Mean (SD)

Mean (SD)

3.0 (1.3)

2.6 (1.4)

Pages viewed
General test information (4 pages)
Health conditions information (8 pages)

2.4 (2.8)

1.8 (2.5)

Genes information (15 pages)

3.6 (4.5)

2.5 (4.0)

5.5 (1.0)

4.9 (1.0)

b
a
b

3.2 (1.2)
2.7 (3.0)
4.4 (5.0)

Perceptions of content
Overall perceptions of content
Trusted information

6.2 (1.1)

5.5 (1.5)

Satisfied with information

5.9 (1.2)

5.1 (1.5)

Easy to understand

5.7 (1.4)

5.0 (1.6)

Able to understand

5.6 (1.7)

5.0 (1.8)
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c
c
c
c
c

5.5 (1.0)
6.0 (1.2)
5.9 (1.2)
5.6 (1.5)
5.5 (1.8)
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Helped decision

5.4 (1.7)

4.7 (1.5)

Minimal effort to understand

5.3 (1.8)

4.6 (1.9)

Sufficient information

4.8 (1.9)

4.4 (1.9)

a

P < .05

b

P < .01

c

P < .001

c
c
a

5.4 (1.6)
5.2 (1.8)
4.7 (1.9)

Table 2

Prediction of ease of decision making by number of pages viewed in a multivariate logistic regression model
(n = 523)
Odds Ratio

95% Confidence

Number of pages viewed

1.04

(1.011.07)

Male gender

0.87

(0.581.29)

Age

0.99

(0.941.04)

High school or less

0.81

(0.471.39)

Some college

0.74

(0.491.13)

White

1.00

(0.492.05)

Black

0.58

(0.291.19)

Married/partnered

0.96

(0.641.45)

Number of conditions with family history

0.94

(0.821.07)

Genetic selfefficacy

1.27

(1.051.52)

Involvement with genetic information

1.18

(1.031.36)

Education

a

b
Race

a

Comparison category is college degree or higher.

b

Comparison category is “other.”

Table 3

Prediction of decision to test by number of pages viewed in a multivariate logistic regression model (n = 523)
Odds Ratio

95% Confidence

Number of pages viewed

1.08

(1.051.11)

Male gender

1.26

(0.851.89)

Age

1.03

(0.991.08)

High school or less

0.51

(0.290.88)

Some college

1.04

(0.691.59)

Education

a

b
Race
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956320/?report=printable
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White

1.65

(0.843.26)

Black

0.66

(0.331.30)

Married/partnered

0.91

(0.601.38)

Number of conditions with family history

1.10

(0.971.26)

Genetic self efficacy

1.24

(1.031.50)

Involvement with genetic information

1.24

(1.071.44)

a Comparison category is college degree or higher.
b Comparison category is “other.”
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